Dieter Erge

Title: The Innovative Contributions of Dieter Erge

Introduction

Dieter Erge is a notable inventor based in Halle, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the production of ergoline derivatives. His work has implications for various medical applications, showcasing the importance of innovation in the pharmaceutical industry.

Latest Patents

Dieter Erge holds a patent for a process related to the fermentation production of ergoline derivatives. This patent involves the creation of alkaloids and 9,10-dihydroalkaloids from the ergotoxine group, including ergometrine. The process includes forming a submerged culture under aerobic conditions by inoculating an aqueous medium with a carbon source, nitrogen sources, and nutrient salts. The inoculum consists of spores from a strain of Claviceps purpurea, which is deposited under number IMET PA 130. After cultivation, the alkaloids are extracted from the culture, and if necessary, they are further processed into pharmaceutically acceptable acid addition salts. This innovative approach highlights the potential for developing new pharmaceutical products.

Career Highlights

Dieter Erge is associated with Veb Arzneimittelwerk Dresden, where he has contributed to various research and development projects. His expertise in fermentation processes and alkaloid production has positioned him as a key figure in his field. With a focus on practical applications of his research, he has been instrumental in advancing the understanding of ergoline derivatives.

Collaborations

Dieter has worked alongside notable colleagues such as Eva Borowski and Klaus Braun. Their collaborative efforts have fostered a productive research environment, leading to advancements in pharmaceutical innovations.

Conclusion

Dieter Erge's contributions to the field of pharmaceuticals through his innovative patent and collaborative work underscore the importance of research and development in creating new medical solutions. His dedication to advancing the production of ergoline derivatives exemplifies the impact of inventors in the healthcare industry.